FATE
Fate Therapeutics, Inc. (FATE) PESTLE Analysis Analysis (2026)
Political
No material political/regulatory catalysts were identified in the latest data.
Economic
The company remains loss-making with negative TTM margins and cash flow, while valuation remains elevated at 43.6x price-to-sales and 50.3x EV-to-sales.
Social
No new news indicates a change in public perception, patient demand, or adoption trends this month.
Technological
High R&D intensity at 15.0% of revenue suggests continued investment in pipeline development.
Legal
No material litigation or legal developments were reported in the latest news flow.
Environmental
No material environmental developments were reported this month.
Overall Score
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Fate Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.